Tretinoin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62032-413 -
Package NDC
62032-413-20 -
Application number
NDA022070 -
SPL ID
cf3898ce-f8a0-4e8f-a237-a8d87e3c20a3 -
SPL set ID
c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b -
UNII
5688UTC01R -
RxCUI
245723
What the source publishes
- Labeler
- Obagi Cosmeceuticals LLC
- Active ingredients
- Tretinoin
- Form
- GEL
- Routes
- TOPICAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Tretinoin",
"splId": "cf3898ce-f8a0-4e8f-a237-a8d87e3c20a3",
"labels": [
{
"setId": "c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b"
}
],
"routes": [
"TOPICAL"
],
"labeler": "Obagi Cosmeceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "20 g in 1 TUBE (62032-413-20)",
"package_ndc": "62032-413-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20140619"
}
],
"productId": "62032-413_cf3898ce-f8a0-4e8f-a237-a8d87e3c20a3",
"useDomain": "unknown",
"dosageForm": "GEL",
"productNdc": "62032-413",
"deaSchedule": null,
"genericName": "Tretinoin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TRETINOIN",
"strength": ".05 g/100g"
}
],
"applicationNumber": "NDA022070",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140619",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175607",
"M0018962"
],
"unii": [
"5688UTC01R"
],
"rxcui": [
"245723"
],
"spl_set_id": [
"c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b"
],
"pharm_class_cs": [
"Retinoids [CS]"
],
"pharm_class_epc": [
"Retinoid [EPC]"
],
"manufacturer_name": [
"Obagi Cosmeceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62032-413_cf3898ce-f8a0-4e8f-a237-a8d87e3c20a3"